Clinical trial
Safety and Efficacy Study of Mix Vaccine in Colorectal Cancer Patient
NCT03357276 is registered in ClinicalTrials.gov with Fuda Cancer Hospital, Guangzhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Study of Mix Vaccine in Colorectal Cancer Patient
- Lead sponsor
- Fuda Cancer Hospital, Guangzhou
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- November 30, 2017
- Completion date
- August 30, 2019
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic colorectal cancer, reaction - mixed vaccine